LYMPHOMA, SMALL LYMPHOCYTIC
Clinical trials for LYMPHOMA, SMALL LYMPHOCYTIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, SMALL LYMPHOCYTIC trials appear
Sign up with your email to follow new studies for LYMPHOMA, SMALL LYMPHOCYTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or stopped responding to at least one prior treatment. The main goal is to see if a new oral drug, nemtabrutinib, combined with venetoclax, works better and is a…
Matched conditions: LYMPHOMA, SMALL LYMPHOCYTIC
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
New CAR-T cell therapy trial offers hope for patients with Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing an experimental cell therapy called JCAR017 for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or hasn't responded to other treatments. The therapy involves modifying a patient's own immune cells to figh…
Matched conditions: LYMPHOMA, SMALL LYMPHOCYTIC
Phase: PHASE1, PHASE2 • Sponsor: Juno Therapeutics, a Subsidiary of Celgene • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
15-Year watch: tracking cancer patients after revolutionary cell therapy
Knowledge-focused Recruiting nowThis study aims to monitor the long-term health of 500 patients who have already received CAR-T cell therapy for various blood cancers in earlier trials. Researchers will follow these patients for up to 15 years to check for any late-developing side effects, such as new cancers o…
Matched conditions: LYMPHOMA, SMALL LYMPHOCYTIC
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC